Lab Tests Face Revaluation, Cuts Under New CMS Proposals
This article was originally published in The Gray Sheet
Executive Summary
CMS is proposing a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are proposed in the agency’s 2014 physician fee schedule draft.
You may also be interested in...
CMS Lessens Lab Test Cuts, Finalizes Revaluation Proposal In Physician Fee Schedule
In the final 2014 physician fee schedule rule, CMS scaled back cuts to independent labs from 26 percent to 5 percent. But it moved ahead with its proposal to update individual lab payments based on technological changes, a move that might lead to reductions over the long term.
CMS Lessens Lab Test Cuts, Finalizes Revaluation Proposal In Physician Fee Schedule
In the final 2014 physician fee schedule rule, CMS scaled back cuts to independent labs from 26 percent to 5 percent. But it moved ahead with its proposal to update individual lab payments based on technological changes, a move that might lead to reductions over the long term.
MolDx Labs Question Missing Medicare Payment Amounts For Some Test Codes
Clinical laboratories plan to talk to CMS about its decision to list only 65 out of 114 new molecular pathology codes when it released revised gap-fill pricing Sept. 30, as well as their concerns about perceived changes to the gap-fill regulation.